Table 1. The pros and cons of humanized mice by human stem cell and tissues transplantation.
Cell sources | Pro | Con | Ref. | |
---|---|---|---|---|
PBL | Human PB lymphocyte | 1. Easy to establish 2. GVHD model | 1. Inability of human LT-HSC | Mosier et al., 1988; Tary-Lehmann et al., 1995 |
2. Good model for xenogeneic GVHD | 2. Anergic naïve and memory T cells | Gleichmann et al., 1984; Garcia et al., 1997; Tary-Lehmann and Saxon, 1992 | ||
3. Initiation to generate lymphoid cells | 3. The lacks of functional human lymphoid cells | Tsuchida et al., 1997; Dessureault et al., 1997; Tary-Lehmann and Saxon, 1992 | ||
4. Uncontrolled B cell activation | Williams et al., 1992; Abedi et al., 1992; Gleichmann et al., 1984 | |||
SRC | Hematopoietic stem cells from a variety of sources | 1. Establishment of LT-HSC | 1. The lacks of educated human T cell | Hiramatsu et al., 2003; Ishikawa et al., 2005; Melkus et al., 2006 |
2. Generation of human immune system | 2. Restriction system for genetic traits | Cany et al., 2013; McCune et al., 1988; Smith et al., 2016 | ||
3. High engraftment of NK cells and CD3 lymphoid cells | 3. Uncontrolled or spontaneously generation of B cells without maturation | Manz, 2007; Melkus et al., 2006 | ||
BLT | Human BM, liver, thymus | 1. Environmental mimicking and complete human immune system | 1. Inadequate for all HLA types | McCune et al., 1988; Wege et al., 2008; Smith et al., 2016; Melkus et al., 2006 |
2. Generation of HLA restricted T cells | 2. Requirement of human epitopes for high diversity | Shultz et al., 2010; Takaki et al., 2006; Niens et al., 2011; Ishikawa et al., 2005 | ||
3. Human mucosal immune system completion | 3. The developmental failure of GVHD | McCune et al., 1988; Lan et al., 2006; Karpel et al., 2015; Lavender et al., 2013 |
PBL, peripheral blood lymphocyte; PB, peripheral blood; GVHD, graft-versus host disease; LT-HSC, long term hematopoietic stem cell; SRC, scid repopulating cells; NK, natural killer; BLT, bone marrow liver thymus; BM, bone marrow, HLA, human leukocyte antigen.